CVS HEALTH CORPORATION Deferred State and Local Income Tax Expense (Benefit)
CVS HEALTH CORPORATION (CVS) reported Deferred State and Local Income Tax Expense (Benefit) of $10.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-10
- CVS HEALTH CORPORATION deferred state and local income tax expense (benefit) for fiscal 2025 was $10.00M.
- CVS HEALTH CORPORATION deferred state and local income tax expense (benefit) for fiscal 2024 was -$119.00M.
- CVS HEALTH CORPORATION deferred state and local income tax expense (benefit) for fiscal 2023 was -$139.00M.
- CVS HEALTH CORPORATION deferred state and local income tax expense (benefit) for fiscal 2022 was -$503.00M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $10.00M 10-K · filed 2026-02-10 | |
| 2024-12-31 | -$119.00M 10-K · filed 2026-02-10 | |
| 2023-12-31 | -$139.00M 10-K · filed 2026-02-10 | |
| 2022-12-31 | -$503.00M 10-K · filed 2025-02-12 | -$506.00M 10-K · filed 2023-02-08 |
| 2021-12-31 | -$120.00M 10-K · filed 2024-02-07 | -$122.00M 10-K · filed 2022-02-09 |
| 2020-12-31 | -$114.00M 8-K · filed 2023-05-25 | |
| 2019-12-31 | -$114.00M 10-K · filed 2022-02-09 | |
| 2018-12-31 | $1.00M 10-K · filed 2021-02-16 | |
| 2017-12-31 | $14.00M 10-K · filed 2020-02-18 | |
| 2016-12-31 | -$2.00M 8-K · filed 2019-08-08 | |
| 2015-12-31 | -$54.00M 10-K · filed 2018-02-14 | |
| 2014-12-31 | $0.00 10-K · filed 2017-02-09 | |
| 2013-12-31 | -$17.00M 10-K · filed 2016-02-09 | |
| 2012-12-31 | -$18.00M 10-K · filed 2015-02-10 | |
| 2011-12-31 | $12.00M 10-K · filed 2014-02-11 | |
| 2010-12-31 | -$5.00M 10-K · filed 2013-02-15 | |
| 2009-12-31 | $4.00M 10-K · filed 2012-02-17 | |
| 2008-12-31 | $15.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |